Skip to main content
. 2022 Jun 20;204:105367. doi: 10.1016/j.antiviral.2022.105367

Table 1.

Kinase inhibitors with anti-NAK activity used in this study. Dissociation constant (Kd), enzymatic activity (IC50), percent binding of control (% of control) values measured in vitro on the four NAKs and NanoBRET GAK IC50 values measured in cells of the indicated kinase inhibitors. The source of KINOMEscan data (if available) and other targets of these compounds are also shown. Kd, IC50, and % of control are shown as *, ** and *** respectively. ^ represents data obtained in this study.

Compound Status Kd*,IC50(nM)**or%ofcontrol
NanoBRET GAK IC50 (nM) Reference Kinome Other targets
AAK1 BIKE GAK STK16
(5Z)-7- Oxozeaenol Investigational 13%*** 3.8%*** 10%*** 100%*** NA Pu et al.,2020 ID: 20211 TAK1 (8 nM), VEGFR2 (52 nM), ERK2 (80 nM)
Sunitinib Approved (cancer) 11 nM* 5.5 nM* 20 nM* 250 nM* NA Davis et al.,2011 Davis et al.,2011 VEGFR2 (80 nM), PDGFRβ (2 nM), FLT3, KIT, PDGFRα
Erlotinib Approved (cancer) 1200 nM* 1200 nM* 3 nM* >9000 nM* 910 nM Asquith et al., 2019a, Asquith et al., 2019b Davis et al.,2011 ErbB1 (0.7 nM), STK10 (19 nM), YSK4 (25 nM), SLK (26 nM)
Gefitinib Approved (cancer) >10,000 nM**a >10,000 nM**a 13 nM* NA 420 nM Asquith et al., 2019a, Asquith et al., 2019b Davis et al.,2011 EGFR
Baricitinib Approved (RA) 17 nM* 40 nM* 134 nM 69 nM* NA Stebbing et al.,2021 Klaeger et al.,2017 JAK1 (5.9 nM), JAK2 (5.7 nM), ROCK1/2, TYK2 (53 nM), CAMK2A, MAP3K2, PRPF4B
RMC-76 Experimental 4 nM** 3.8 nM*a 280 nM*a NA NA Figure S1 NA CDC42BPB, PRKD3, CLK1, CLK4, ULK3, MINK1
RMC-242 Experimental 4100 nM*a >15000 n M*a 12 nM** NA 78 nMa Martinez-Gualda et al.,2021 NA NA
SGC-GAK-1 Experimental NA
86%***
NA
92%***
2 nM*
9.7%***
NA
84%***
48 nM Asquith et al., 2019a, Asquith et al., 2019b Asquith et al., 2019a, Asquith et al., 2019b RIPK2 (110 nM), ADCK3 (190 nM), NLK (520 nM)
STK-16-1N-1 Experimental NA
13%***
NA
9.5%***
NA
46%***
295 nM**
0.65%***
NA Liu et al., 2016 Liu et al.,2016 PI3Kδ (856 nM), PI3Kγ (867 nM)
a

Data obtained in this study, RA= Rheumatoid Arthritis